Page last updated: 2024-12-08

murexine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

murexine: muscle relaxant; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5458497
CHEMBL ID2008613
SCHEMBL ID3124240
MeSH IDM0052520

Synonyms (14)

Synonym
20284-40-6
ethanaminium, 2-((3-(1h-imidazol-4-yl)-1-oxo-2-propenyl)oxy)-n,n,n-trimethyl-
choline, chloride, imidazole-4-acrylate
unii-bn6x05a90p
bn6x05a90p ,
beta-(4-imidazolyl)acryloylcholine
murexine
SCHEMBL3124240
CHEMBL2008613
ethanaminium, 2-((3-(1h-imidazol-5-yl)-1-oxo-2-propen-1-yl)oxy)-n,n,n-trimethyl-
choline, imidazole-4-acrylate (ester)
murexine [mi]
Q11786689
ethanaminium, 2-[[3-(1h-imidazol-5-yl)-1-oxo-2-propen-1-yl]oxy]-n,n,n-trimethyl-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (86.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]